| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 05/17/2006 | EP1296711B1 Hpv-e7 for human papilloma virus treatment |
| 05/17/2006 | EP1117693B1 Intein mediated peptide ligation |
| 05/17/2006 | EP0975668B1 MODIFIED TNFalpha MOLECULES, DNA ENCODING SUCH MODIFIED TNFalpha MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNFalpha MOLECULES AND DNA |
| 05/17/2006 | EP0973391B1 Endoderm, cardiac and neural inducing factors |
| 05/17/2006 | EP0796273B1 Variants of human papilloma virus antigens |
| 05/17/2006 | CN1774447A S. pneumoniae antigens |
| 05/17/2006 | CN1256591C HCV antigen/antibody combination assay |
| 05/17/2006 | CN1256347C Fusion protein of kininogen D5 and tumor necrosis factor related apoptosis-inducing ligand(D5-TRAIL), its preparation and use thereof |
| 05/16/2006 | US7045498 Soluble Zcytor11 cytokine receptors |
| 05/16/2006 | US7045318 Recombinant fusion proteins to growth hormone and serum albumin |
| 05/16/2006 | US7045302 Expressed ligand-vascular intercellular signaling molecule |
| 05/16/2006 | US7045129 Method of treating cancer including administering a human chimeric antibody specific for the ganglioside GD3 |
| 05/16/2006 | CA2129183C Bispecific trigger molecules recognizing lymphocyte antigen cd2 and tumor antigens |
| 05/11/2006 | WO2006049440A1 Method for producing epidermal growth factor using fusion proteins comprising f a s-1 domain |
| 05/11/2006 | WO2006048491A1 Biosensor based on peptide nucleic acid (pna) molecules on gold surfaces, production method thereof and uses of same |
| 05/11/2006 | WO2005118647A3 M13 virus major coat protein variants for c-terminal and bi-terminal display of a heterologous protein |
| 05/11/2006 | WO2005003177A3 Molecules for the targeting and the in situ assembly of therapeutic proteins and use thereof |
| 05/11/2006 | US20060100141 Administering peptidic or peptidomimetic compound having segment competent for importation of molecule into mast cells, and asecond segment for having an anti-allergic effect within mast cells for reducing late phase inflammatory responses induced by mitogen activated protein kinase activation |
| 05/11/2006 | US20060100135 Compositions and methods for modifying toxic effects of proteinaceous compounds |
| 05/11/2006 | US20060100134 fusion proteins; drug delivery |
| 05/11/2006 | US20060099677 DNA/RNA transduction technology and its clinical and basic applications |
| 05/11/2006 | US20060099672 Polypeptides with a functional binding domain, translocation domain, a therapeutic domain and a non-native protease cleavage site for cleavage in vitro following expression as a single chain; efficient, less dangerous production method; botulinum neurotoxins targeted to specific cell types for example |
| 05/11/2006 | US20060099635 Anti-GL50 antibodies |
| 05/11/2006 | US20060099216 Peptide delivery |
| 05/11/2006 | DE3571648C5 Monoklonale Antikörper gegen menschlichen Brustkrebs, ihre Produktion und Verwendung, Hybridomen zu ihrer Herstellung und Herstellung dieser Hybridomen. Monoclonal antibodies against human breast cancer, their production and use, hybridomas for their preparation and production of these hybridomas. |
| 05/10/2006 | EP1006782B1 Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid |
| 05/10/2006 | EP0972055B1 METHOD FOR PRODUCING PURIFIED AND MARKED TSH RECEPTOR PREPARATIONS AND THE USE OF the corresponding PREPARATIONS IN DIAGNOSTICS |
| 05/10/2006 | EP0809700B1 Papilloma virus-like particles, fusion proteins and process for producing the same |
| 05/10/2006 | CN1769300A Tumour new-born blood vessel specific binding polypeptide CRGDC and novel recombinant tumor necrosis factor nrhTNF fusion protein and their preparation method |
| 05/10/2006 | CN1769299A Novel fusion protein production and uses |
| 05/10/2006 | CN1769298A Fusion protein with antitumour action and its coding gene and uses |
| 05/10/2006 | CN1768862A Protein marked by Tc-99 capable of specifically combined with GnRH-receptor expressed cancer cell |
| 05/10/2006 | CN1255543C Expression and application of transduction peptides - human insulinogen fusion protein |
| 05/10/2006 | CN1255540C Vaccine-induced hepatitis B viral strain and uses thereof |
| 05/09/2006 | US7041796 C3b/C4b Complement Receptor-like molecules and uses thereof |
| 05/09/2006 | US7041793 Fusion protein comprising a cellulose binding domain and a domain having a high binding affinity for another ligand. |
| 05/09/2006 | US7041788 Multimerized highly functional antifreeze protein |
| 05/09/2006 | US7041478 Polypeptide for use in the treatment cancer, inflammation of autoimmune disorders |
| 05/09/2006 | US7041295 Compounds for treatment of infectious and immune system disorders and methods for their use |
| 05/09/2006 | US7041290 isolated monoclonal antibody or antigen-binding-fragment thereof that binds to the extracellular domain of the human KIM-1 polypeptide of an epitope within or overlapping the amino acid sequence: SSDGLWNNNQTQLFLEHS; treating or preventing renal disease or injury |
| 05/04/2006 | WO2006046693A1 Method of assyaing htlv-i-specific t cell response |
| 05/04/2006 | US20060094862 Specificity exchangers that redirect antibodies to a pathogen |
| 05/04/2006 | US20060093613 Soluble T cell receptor |
| 05/04/2006 | CA2584986A1 Use of apoptosis inhibiting compounds in degenerative neurological disorders |
| 05/03/2006 | EP1652934A1 Improved method of amplifying atp and use thereof |
| 05/03/2006 | EP1652918A2 Methods for detecting protein interactions using conformationally constrained peptides |
| 05/03/2006 | EP1651665A1 Method for the purification of a non-immunoglobulin protein comprising an immunoglobulin-like (ig-like) domain |
| 05/03/2006 | EP1651258A2 Hepatitis virus core proteins as vaccine platforms and methods of use thereof |
| 05/03/2006 | EP1042491B1 Maize h3c4 promoter associated with first rice actin intron, chimeric gene containing it and transformed plant |
| 05/03/2006 | CN1768079A Polypeptide |
| 05/03/2006 | CN1766115A Preparation method of fusion protein of tumour blood-targeted peptide and human interferon alpha-2b |
| 05/03/2006 | CN1766108A T1R taste receptors and genes encoding same |
| 05/03/2006 | CN1765932A Fusion protein of extrasin alpha1 and interferon |
| 05/03/2006 | CN1765931A GLP-1 fusion protein and its preparation method and medicinal uses |
| 05/03/2006 | CN1765930A Method for enhancing antiseptic peptide stability and its application |
| 05/03/2006 | CN1765929A Fusion protein and nucleic acid containing peptide carrier and epidermal growth factor and its uses |
| 05/03/2006 | CN1254542C Methods for the recombinant production of antifusogenic peptides |
| 05/03/2006 | CN1254272C Activation and inhibition of immune system |
| 05/03/2006 | CN1254271C Hybrid polypeptides with enhanced pharmacokinetic properties |
| 05/02/2006 | US7038035 Nucleic acids codes polypeptides; mutants; insertion a vector; culturing; recovering |
| 05/02/2006 | US7038022 Multimeric protein; complexing with steroids, thyroid; modulate transcription of genes under hormone expression control |
| 05/02/2006 | US7037699 Human extracellular signal regulated kinases |
| 05/02/2006 | CA2149529C Peptides and anti-sense peptides with broad neoplastic specificity |
| 04/27/2006 | WO2006044410A2 A32 monoclonal antibody fusion proteins for use as hiv inhibitors and vaccines |
| 04/27/2006 | WO2005092918A3 Targeting polypeptide |
| 04/27/2006 | US20060088908 Mutiens of human neutrophil gelatinase-associated lipocalin and related proteins |
| 04/27/2006 | US20060088878 Purification of recombinant proteins fused to multiple epitopes |
| 04/27/2006 | US20060088548 Chimeric peptides as immunogens, antibodies thereto, and methods for immunization using chimeric peptides or antibodies |
| 04/27/2006 | US20060088537 Protein involved in cancer |
| 04/27/2006 | US20060088532 Lymphatic and blood endothelial cell genes |
| 04/27/2006 | CA2584108A1 Development of sensitive fret sensors and methods of using the same |
| 04/27/2006 | CA2583937A1 Chimeric protein |
| 04/26/2006 | EP1650225A1 Hetero type pentamer recombinant vaccine |
| 04/26/2006 | EP1650219A1 Human toll homologues |
| 04/26/2006 | EP1648388A2 Novel targets and compositions for use in decontamination, immunoprophylaxis, and post-exposure therapy against anthrax |
| 04/26/2006 | EP1474521B1 An herpes simplex virus complex |
| 04/26/2006 | EP1187918B1 Tek antagonists |
| 04/26/2006 | EP0850305B1 Compounds and methods for diagnosis of tuberculosis |
| 04/26/2006 | EP0773997B1 Htk ligand |
| 04/26/2006 | CN1763203A Gene recombinant human cytomegalovirus fusion protein pp150/MDBP, preparation process and application thereof |
| 04/26/2006 | CN1763187A Recombinant serine protease and fungicide containing the same |
| 04/26/2006 | CN1763106A Antiviral fusion protein and its coding gene and uses |
| 04/26/2006 | CN1763105A Fusion protein for stimulating organism to produce FMDV antibody and its coding gene and uses |
| 04/26/2006 | CN1763104A Recombinant pronucleus expressed and detected antigen for VII genetype newcastle disease virus NP antibody and its preparation method |
| 04/25/2006 | US7034137 Isolated mammalian membrane protein genes; related reagents |
| 04/25/2006 | US7034125 Comprises neurotransmitter transport protein for monitoring and evaluating modulators of neuronal signaling; diagnosis and treatment of schizophrenia, epilepsy, depression, learning and neurodegenerative disorders |
| 04/25/2006 | US7034114 Polypeptide for use in the treatment of inflammation, atherosclerosis, nervous system, blood, muscular, connective tissue and cancer disorders |
| 04/25/2006 | US7034109 Intracellular delivery of biological effectors |
| 04/25/2006 | US7033828 Nucleic acid encoding gamma retinoic acid receptor fusion protein |
| 04/25/2006 | US7033807 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase |
| 04/25/2006 | US7033805 Contains amino acid motifs of a serine proteinase, a nucleotide triphosphatase (NTPase), and an RNA helicase. |
| 04/25/2006 | US7033794 Basolateral sorting signal and inhibitors thereof |
| 04/25/2006 | US7033791 Nucleic acid molecules encoding modified factor VIII proteins, expression products, and methods of making the same |
| 04/25/2006 | US7033770 Comprises winglesslint 8D (Wnt-8D) polypeptides for treating asthma, nervous system, psychological, alzheimer, cancer, cardiomyopathies, lung and kidney disorders; wound healing agents; tissue engineering |
| 04/25/2006 | US7033751 Comprises viral glycoprotein fusion with glutathione s-tranferase (GST) or thioredoxin for use as diagnostic tool in screening blood products for retroviral infection |
| 04/25/2006 | US7033572 Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system |
| 04/25/2006 | CA2236912C Vectors and methods for gene transfer to cells |
| 04/22/2006 | CA2481452A1 Novel purified polypeptides from streptococcus pneumoniae |
| 04/20/2006 | WO2006041211A1 Protein capable of binding to plasticizer |
| 04/20/2006 | WO2006041130A1 Gel for zymography |